Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Myo-Inositol wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Probably helps
7 of 12 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (2)
Outcomes where both D-Chiro-Inositol and Myo-Inositol have evidence — compare verdict strength side-by-side.
Best used as myo-inositol:D-chiro-inositol 40:1 (e.g. 2000mg MI : 50mg DCI); DCI alone is not recommended at high doses
with-meals
D-chiro-inositol within a 40:1 myo-inositol blend
2-4g daily for PCOS; up to 12-18g for anxiety
Divided doses with meals, Morning and evening
Myo-inositol powder
8-12 weeks
8-12 weeks
Throughout use
3-6 months
4-6 weeks
2-3 months
Initial use or high doses
Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines.
J Clin Endocrinol Metab (2024) · Meta analysis
Possible metabolic and ovulatory benefit signals for inositols in PCOS
Efficacy of myo-inositol and d-chiro-inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open-label study.
Int J Gynaecol Obstet (2022) · Rct
Spontaneous menses resumed in ~84% of women with PCOS
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Cochrane Database Syst Rev (2017) · Meta analysis
Insulin-sensitizing agents improved PCOS outcomes (driven largely by metformin)
Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes
The Cochrane database of systematic reviews (2023) · Meta analysis · n=1319
For the primary neonatal outcomes, only one study measured the risk of a large-for-gestational-age infant and found myo-inositol was associated with both appreciable benefit and harm (RR 1.40, 95% CI 0.65 to 3.02; 1 study, 234 infants; low-certainty evidence).
Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Nutrients (2022) · Meta analysis · n=1321
Pooled results were expressed as relative risk (RR) or mean difference (MD) with a 95% confidence interval (95% CI).
Short period-administration of myo-inositol and metformin on hormonal and glycolipid profiles in patients with polycystic ovary syndrome: a systematic review and updated meta-analysis of randomized controlled trials
European review for medical and pharmacological sciences (2022) · Meta analysis · n=612
Compared with metformin, the suitable supplemental dosage of myo-ins may be helpful in lowering levels of TG and avoiding adverse events (AEs).
Based on multiple meta-analyses showing improved menstrual regularity and ovulation in PCOS. Evidence quality varies across studies with some showing minimal differences vs placebo. 4g daily most commonly studied dose.
AI-estimated from published studies. Interpret as directional guidance.
Myo-Inositol has a higher evidence score (9/10 vs 4.2/10) and wins in 3 of 3 categories.
For manage blood sugar, Myo-Inositol has a higher relevance score (85 vs 40).
No known interactions between D-Chiro-Inositol and Myo-Inositol have been documented in our database. However, always consult a healthcare provider before combining supplements.